By LIZ NEPORENT From: abcnews.go.com Women between the ages of 40 to 49 should get a mammography to screen for breast cancer if they’ve weighed the risks and benefits, the United States Preventative Services Task Force said in a statement. “The group’s top level recommendations that women should begin mammogram testing at age 50 and only schedule them every two …
Personalizing Cancer Treatment With Genetic Tests Can Be Tricky
By: Richard Harris From: npr.org It’s becoming routine for cancer doctors to order a detailed genetic test of a patient’s tumor to help guide treatment, but often those results are ambiguous. Researchers writing in Science Translational Medicine Wednesday say there’s a way to make these expensive tests more useful. Here’s the issue: These genomic tests scan hundreds or even thousands …
Breast Tumor Stiffness and Metastasis Risk Linked by Molecule’s Movement
Stiffness drives cancer invasion through previously unknown mechanism Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and poor prognosis. The study, published April 20 in Nature Cell Biology, may inspire new approaches to predicting patient outcomes and halting tumor metastasis. …
Breath test ‘could give clues to stomach cancer risk’
By: Smitha Mundasad From: bbc.com A simple breath test could help predict whether people with gut problems are at high risk of developing stomach cancer, an early study shows. It detects chemical compounds in people’s breath, in an attempt to distinguish unique “breath prints” in those with risky pre-cancerous changes. Experts say if proven in large trials, it could spot …
Let Life Happen Voted A Top Best Breast Cancer Blog For 4th Year In A Row
View PostStudy finds troubling link between use of muscle-building supplements and cancer
By: Abby Phillip From: washingtonpost.com The growth in popularity of dietary supplements has come largely despite a lack of scientific evidence to back up claims that they work. There are, however, growing questions about their risks. The latest: A new study, published in the British Journal of Cancer on Monday, found evidence of a troubling connection between men who took muscle-building supplements …
A Clam Cancer Outbreak, Spread by One Set of Cells
By: JAMES GORMAN From: nytimes.com The idea that infectious cancer cells are drifting in the ocean, spreading a devastating leukemia-like disease may sound like a dystopian fantasy. But scientists say that is exactly what is happening — in clams. It is no surprise that clams suffer from the disease. For at least 40 years, outbreaks of the clam equivalent of …
Israeli team finds two proteins that can suppress cancer
By: Times of Israel Staff From: timesofisrael.com A team of Israeli researchers at the Technion has discovered two proteins that can suppress cancer and control the cells’ growth and development. The study was conducted in the laboratory of Prof. Aaron Ciechanover, an Israeli Nobel-prize winner in chemistry, and led by Dr. Yelena Kravtsova-Ivantsiv. The team included research students and physicians from the Rambam, Carmel …
Breast Cancer Website Launched to Provide Info on Dense Breasts
Nonprofit Group Educates Women on Dense Breast Risks, Urging Them to ‘Get Smart about Being Dense’ Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website. The site, www.DenseBreast-info.org, addresses questions women and their healthcare providers often have about breast density …
Agendia Announces Recommendation of MammaPrint in Germany’s AGO Guidelines
Company Also Highlights FDA Clearance of MammaPrint in FFPE RVINE, CA and AMSTERDAM, THE NETHERLANDS – Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for …